Intrinsic Value of S&P & Nasdaq Contact Us

Intuitive Surgical, Inc. ISRG NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
81/100
6/7 Pass
SharesGrow Intrinsic Value
$259.27
-44.5%
Analyst Price Target
$638.75
+36.7%

Intuitive Surgical, Inc. (ISRG) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $467.22. It has a SharesGrow Score of 81/100, indicating a strong investment profile with 6 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of ISRG = $259.27 (-44.5% from the current price, the stock appears overvalued). Analyst consensus target is ISRG = $639 (+36.7% upside).

Valuation: ISRG trades at a trailing Price-to-Earnings (P/E) of 56.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 4.

Financials: revenue is $10.1B, +17.4%/yr average growth. Net income is $2.9B, growing at +29.4%/yr. Net profit margin is 28.4% (strong). Gross margin is 66% (-1.4 pp trend).

Balance sheet: total debt is $303M against $17.8B equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 4.87 (strong liquidity). Debt-to-assets is 1.5%. Total assets: $20.6B.

Analyst outlook: 37 / 54 analysts rate ISRG as buy (69%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 31/100 (Fail), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 86/100 (Pass), Future 73/100 (Pass), Income 85/100 (Pass).

$638.75
▲ 36.71% Upside
Average Price Target
Based on 54 Wall Street analysts offering 12-month price targets for Intuitive Surgical, Inc., the average price target is $638.75, with a high forecast of $750.00, and a low forecast of $550.00.
Highest Price Target
$750.00
Average Price Target
$638.75
Lowest Price Target
$550.00

ISRG SharesGrow Score Overview

81/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 31/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 86/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 85/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ISRG

VALUE Fail
31/100
ISRG trades at a trailing Price-to-Earnings (P/E) of 56.6 (S&P 500 average ~25). Forward PEG 4 — overvalued. Trailing PEG 13.61. Analyst consensus target is $639, implying +36.8% from the current price $467. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
90/100
ISRG: +17.4%/yr revenue is, +29.4%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
ISRG: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet ISRG: Debt-to-Equity (D/E) ratio 0.02 (conservative), Current ratio is 4.87 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Pass
86/100
ISRG: Gross margin is 66% (-1.4 pp trend), $166B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 86/100. ≥ 70 = Pass.
View details →
FUTURE Pass
73/100
Analyst outlook: 37 / 54 analysts rate ISRG as buy (69%). Analyst consensus target is $639 (+36.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
85/100
ISRG: Net profit margin is 28.4%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range425-603.88
Volume1.97M
Avg Volume (30D)1.92M
Market Cap$165.94B
Beta (1Y)1.68
Share Statistics
EPS (TTM)8.00
Shares Outstanding$356.9M
IPO Date2000-06-16
Employees15,638
CEODavid J. Rosa
Financial Highlights & Ratios
Revenue (TTM)$10.06B
Gross Profit$6.64B
EBITDA$3.62B
Net Income$2.86B
Operating Income$2.95B
Total Cash$5.93B
Total Debt$302.8M
Net Debt$-3.07B
Total Assets$20.63B
Price / Earnings (P/E)58.4
Price / Sales (P/S)16.49
Analyst Forecast
1Y Price Target$635.00
Target High$750.00
Target Low$550.00
Upside+35.9%
Rating ConsensusBuy
Analysts Covering54
Buy 69% Hold 22% Sell 9%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS46120E6023

Price Chart

ISRG
Intuitive Surgical, Inc.  ·  NASDAQ Global Select
Healthcare • Medical - Instruments & Supplies
425.00 52WK RANGE 603.88
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message